Riik: Malta
keel: inglise
Allikas: Medicines Authority
AMOXICILLIN, CLAVULANIC ACID
Elpen Pharmaceutical Co. Inc. 95 Marathonos Ave., 190 09 Pikermi, Attica, Greece
J01CR02
AMOXICILLIN 125 mg/5ml CLAVULANIC ACID 31.25 mg/5ml
POWDER FOR ORAL SUSPENSION
AMOXICILLIN 125 mg/5ml CLAVULANIC ACID 31.25 mg/5ml
POM
ANTIBACTERIALS FOR SYSTEMIC USE
Withdrawn
2006-11-14
ERROR PAGE The page you requested was not found. Click here to go back Lugege kogu dokumenti
Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. TRADE NAME OF THE MEDICINAL PRODUCT FUGENTIN ® 2. QUALITATIVE AND QUANTITATIVE COMPOSITION FUGENTIN ® film-coated tablets (500 + 125) mg/tab: Each tablet contains 500 mg amoxicillin (as amoxicillin trihydrate) and 125 mg clavulanic acid (as potassium clavulanate). FUGENTIN ® powder for oral suspension (125 + 31.25) mg/5 ml: Each dosimetric spoonful (5 ml of the suspension) contain 125 mg amoxicillin (as amoxicillin trihydrate) and 31.25 mg clavulanic acid (as potassium clavulanate)._ _ FUGENTIN ® powder for oral suspension (250 + 62.5) mg/5 ml: Each dosimetric spoonful (5 ml of the suspension) contain 250 mg amoxicillin (as amoxicillin trihydrate) and 62.5 mg clavulanic acid (as potassium clavulanate)._ _ 3. PHARMACEUTICAL FORM A. Film-coated tablets B. Powder for oral suspension 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS FUGENTIN ® is indicated for short period treatment of bacterial infections, caused by beta-lactamase producing organisms, which are susceptible to this drug. The duration of treatment depends on the therapeutic indication and it must not exceed 14 days. • Upper Respiratory Tract Infections (including ear, nose and throat infections), i.e. recurrent tonsillitis, sinusitis, otitis media (especially in recurrence or in severe cases). • Lower Respiratory Tract Infections i.e. acute exacerbations of chronic bronchitis, lobar pneumonia and bronchopneumonia. • Genitourinary Tract Infections i.e. cystitis, urethritis (not prostatitis), pyelonephritis, infections of the female genital organs (excluding infections caused by chlamydia). • Skin and Soft Tissue Infections. • Bone and Joint Infections i.e. osteomyelitis. • Other Infections i.e. septic abortion, puerperal sepsis, Lugege kogu dokumenti